Inhibitors of SerpinA11 include a diverse group of compounds that disrupt the normal activity of the protein through several biological mechanisms. Some of these compounds block the protein degradation pathways, which leads to the buildup of proteins inside the cell and can ultimately impact the functioning and regulation of SerpinA11. Similarly, a set of inhibitors directly interacts with serine proteases, the main targets of SerpinA11, potentially competing with the serpin for binding to these enzymes and thus impairing its ability to regulate their activity. Other inhibitors also act on these protease targets, adding to the competitive dynamics that may affect the serpin's function.
Further adding to the variety of mechanisms, certain molecules compete with SerpinA11 for binding to proteases, potentially reducing the effectiveness of SerpinA11's regulatory actions. At the same time, a range of inhibitors that focus on other classes of proteases could have indirect consequences for the interactions of SerpinA11 with its protease targets. Inhibitors that target a broader spectrum of proteases may also influence the operational environment of SerpinA11, especially if it is involved in regulating those enzymes. Additionally, compounds that affect gene expression and protein regulation may lead to changes in the expression levels of SerpinA11, thus altering its activity within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that prevents the degradation of proteins, including SerpinA11, allowing its accumulation and thus reducing its functional activity. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
Serine protease inhibitor that might compete with SerpinA11 for target proteases, thereby reducing SerpinA11's functional activity. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
Synthetic serine protease inhibitor that could inhibit the proteolytic activity of SerpinA11 by competitive inhibition. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
A potent serine protease inhibitor that could bind to the same targets as SerpinA11, potentially decreasing SerpinA11's ability to inhibit its target proteases. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
A reversible inhibitor of serine and cysteine proteases that could indirectly inhibit SerpinA11 by inhibiting its target enzymes. | ||||||
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $43.00 $183.00 $312.00 $624.00 $2081.00 $4474.00 | 5 | |
Inhibitor of serine proteases that could reduce the efficacy of SerpinA11 by competitive inhibition at the active sites of shared target proteases. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
Irreversible inhibitor of cysteine proteases that can indirectly inhibit SerpinA11's interaction with cysteine protease targets. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
Irreversible inhibitor of serine proteases that could interfere with SerpinA11's protease inhibition function by binding to the same targets. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Broad-spectrum matrix metalloproteinase inhibitor that could impact SerpinA11's regulatory role on matrix metalloproteases if it is involved. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
PPAR-gamma agonist that modulates gene expression and protein regulation, potentially affecting SerpinA11 expression levels and consequently its activity. | ||||||